METHIMAZOLE MARKET

INTRODUCTION

The drug thiamazole commonly referred to as methimazole is used to treat hyperthyroidism. This comprises thyrotoxic crisis, toxic multinodular goiter, and Graves disease. It is consumed orally. The full results might not show for a few weeks.

Itching, hair loss, nausea, muscle discomfort, edema, and abdominal pain are typical adverse effects. Low blood cell counts, hepatic failure, and vasculitis is examples of severe adverse effects.

Due to the possibility of congenital defects, use is not advised during the first trimester of pregnancy, but it is permitted during the second or third. It can be applied while nursing.

Propylthiouracil side effects may also be an issue for those who experienced major adverse effects. Thiamazole, a thioamide, functions by lowering thyroid hormone synthesis.

Thiamazole is a medication used to treat hyperthyroidism, a condition that develops when the thyroid gland starts to produce too much thyroid hormone and as seen in Graves' disease.

To reduce thyroid hormone levels and lessen the effects of thyroid manipulation, the medication may also be administered prior to thyroid surgery. Thiamazole is also used in veterinary medicine to treat cats with hyperthyroidism.

While taking thiamazole, it's crucial to keep an eye out for any fever or sore throat symptoms, since these could be signs of the emergence of agranulocytosis, a rare but serious side effect brought on by a decline in the white blood cell count (to be specific, neutropenia, a deficiency of neutrophils).

In the event that a complete blood count (CBC) with differential is used to confirm the suspicion, the medication is stopped. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) use could hasten to heal.

The enzyme thyroperoxidase is normally involved in the synthesis of thyroid hormones by oxidizing the anion iodide (I) to iodine (I2), hypoiodous acid (HOI), and enzyme-linked hypoiodate (EOI).

Thiamazole inhibits this enzyme, making it easier for iodine to be added to tyrosine residues on the hormone precursor thyroglobulin, a step (T4).

The basolateral membranes of follicular cells have a sodium-dependent iodide transporter, although it has no effect on its function. Competitive inhibitors like perchlorate and thiocyanate are needed to stop this process.

METHIMAZOLE MARKET SIZE AND FORECAST

The Global METHIMAZOLE market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

METHIMAZOLE MARKET NEW PRODUCT LAUNCH

The 1mg and 2mg strengths of Glycopyrrolate Tablets, an FDA-approved generic version of Shionogi's Robinul and Robinul Forte, as well as the 5mg and 10mg strengths of Methimazole Tablets, an FDA-approved generic version of Shionogi's Robinul and Robinul Forte, are now available, according to ACETO Corporation, a global leader in the marketing, sale, and distribution of Human Health

METHIMAZOLE MARKET COMPANY PROFILES

• ACETO Corporation
• Mylan
• Abbott Laboratories
• GlaxoSmithKline
• Merck
• AbbVie

THIS METHIMAZOLE MARKET REPORT WILL ANSWER THE FOLLOWING QUESTIONS

1. How many METHIMAZOLE are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global METHIMAZOLE and key vendor selection criteria
3. Where is the METHIMAZOLE manufactured? What is the average margin per unit?
4. Market share of Global METHIMAZOLE market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global METHIMAZOLE in-house
6. key predictions for next 5 years in the Global METHIMAZOLE market
7. Average B-2-B METHIMAZOLE market price in all segments
8. Latest trends in the METHIMAZOLE market, by every market segment
9. The market size (both volume and value) of the METHIMAZOLE market in 2024-2030 and every year in between?
10. Production breakup of the METHIMAZOLE market, by suppliers and their OEM relationship